At a time when the word “vaccine” alone can unleash a real ideological war, thanks to research we can still speak clearly. Although there were already scientific grounds to believe this, a recent study has made clear the importance of the quadrivalent vaccine against the papilloma virus. Importance that would go far beyond that of protecting against papilloma infection, which is why it was created. In fact, few people know that this vaccine is the worst enemy of a widespread cancer, that of the cervix (or neck of the uterus). They were the Swedish researchers of the Karolinska Institutet to highlight the relationship between this vaccine and cancer prevention. The news was promptly reported by the AIRC experts, assuming irrefutable relevance.
Few people know that this vaccine is the worst enemy of a widespread tumor
The team of Swedish researchers conducted the research with painstaking care. Thanks to the support of national registers, the group monitored a sample of 1.7 million girls between the ages of 10 and 30. The monitoring lasted 11 years, precisely from 2006 to 2017. The choice of these dates is anything but random. Indeed, in 2006, the vaccine against papilloma virus became mandatory in Sweden. At the time of the survey, about one-third of the girls sampled had had at least one dose of the vaccine.
The results of the observation are, to say the least, disconcerting. Among the vaccinated girls, 19 were ill with cervical cancer. While 538 unvaccinated girls contracted this form of cancer. It is not necessary to be an expert in statistics to draw the first evident conclusions. The quadrivalent vaccine against papilloma virus (specifically against the four HPV variants 6, 11, 16 and 18) is one of the best deterrents against cervical cancer.
The sooner we get vaccinated, the better
Another relevant discovery that has always emerged from the data of the aforementioned research is a truly encouraging percentage. Vaccination against papilloma virus, data in hand, would decrease the risk of cervical cancer by 53%, done between 17 and 30 years. This figure, already exceptional in itself, is even more encouraging if the vaccination is administered between the ages of 10 and 17. In this case, the risk of cervical cancer decreases by 88%. Important numbers, which are worth disclosing
Deepening
Few people know that colon cancer can come from abusing these very common drinks